Key result
The STTGMARisk and STTGMACost triage tools successfully predicted inpatient mortality, with 21.4% of patients in the high-risk group expiring, and correctly identified 88.9% of high-cost patients.
Why the study?
The study was conducted to combine a validated trauma risk assessment tool with a novel cost-prediction tool to create an objective triage tool for elderly hip fractures to guide value-based care initiatives.
Does a combined risk and cost prediction tool (STTGMARisk and STTGMACost) accurately predict inpatient mortality and high costs in elderly hip fracture patients?
Cohort (n=361)
No
Does a combined risk and cost prediction tool (STTGMARisk and STTGMACost) accurately predict inpatient mortality and high costs in elderly hip fracture patients?
A simple risk score calculated upon admission can differentiate mortality risk and predict high-cost patients based on resource utilization in hip fracture patients.
May aid triage in high-risk patients; leaves open prospective validation before clinical adoption.
INTRODUCTION: The purpose of this study was to combine a validated middle-age and geriatric trauma risk assessment tool (STTGMA) with a novel cost-prediction tool to create an objective triage tool for elderly hip fractures that would guide value-based care initiatives. METHODS: From October 2014 to January 2018, all patients aged ≥55 years who were admitted with a primary diagnosis of hip fracture to a single level 1 trauma center were enrolled. Upon evaluation in the emergency department, demographics, injury severity, and functional status were recorded to calculate the trauma triage score (STTGMARisk). A model to predict high-cost hip fracture patients was created using similar variables (STTGMACost). RESULTS: Three hundred sixty-one consecutive operative hip fracture patients were enrolled. Inpatient mortalities were skewed toward STTGMARisk3 with 21.4% of patients in this high-risk group ultimately expiring during their hospitalization. High-cost patients were correctly skewed to the STTGMACost2 and STTGMACost3 groups with 88.9% of all high-cost operatively treated hip fracture correctly triaged to these cohorts. Statistically significant variations were found in cost within each STTGMARisk group. CONCLUSIONS: A simple risk score calculated upon admission (STTGMARisk and STTGMACost) was able to be used as a triage tool not only to differentiate increased mortality risk but also to predict high-cost patients based on resource utilization in hip fracture patients. LEVEL OF EVIDENCE: Prognostic, level II.
No takes yet. Share an insight, caveat, or question.
Konda et al. (2019) conducted a cohort in hip fracture (n=361). STTGMARisk and STTGMACost triage tools was evaluated on Inpatient mortality and high-cost prediction. The STTGMARisk and STTGMACost triage tools successfully predicted inpatient mortality, with 21.4% of patients in the high-risk group expiring, and correctly identified 88.9% of high-cost patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: